Moderna’s coronavirus vaccine shows encouraging early results

Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results Monday from its first human safety tests.

The eagerly awaited data provide a first look at one of the eight vaccines worldwide that have begun human testing. The data have not been published in a scientific journal and are only a preliminary step toward showing the experimental vaccine is safe and effective.